Clinical Trials Browser

Phase 2 × Small Bowel Adenocarcinoma × Gastrointestinal × Clear all

NCT06835387 2026-02-17

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

Phase 2 Recruiting

Gastrointestinal

Small Bowel Adenocarcinoma